345 related articles for article (PubMed ID: 17698346)
1. Switching benchmarks in cancer of unknown primary: from autopsy to microarray.
Pentheroudakis G; Golfinopoulos V; Pavlidis N
Eur J Cancer; 2007 Sep; 43(14):2026-36. PubMed ID: 17698346
[TBL] [Abstract][Full Text] [Related]
2. [Molecular diagnostic methods designed for clinical approach to cancer of unknown origin].
Fujita Y; Nishio K
Gan To Kagaku Ryoho; 2009 Jun; 36(6):923-6. PubMed ID: 19542713
[TBL] [Abstract][Full Text] [Related]
3. Cancer of unknown primary site: missing primary or missing biology?
Pentheroudakis G; Briasoulis E; Pavlidis N
Oncologist; 2007 Apr; 12(4):418-25. PubMed ID: 17470684
[TBL] [Abstract][Full Text] [Related]
4. An expression-based site of origin diagnostic method designed for clinical application to cancer of unknown origin.
Tothill RW; Kowalczyk A; Rischin D; Bousioutas A; Haviv I; van Laar RK; Waring PM; Zalcberg J; Ward R; Biankin AV; Sutherland RL; Henshall SM; Fong K; Pollack JR; Bowtell DD; Holloway AJ
Cancer Res; 2005 May; 65(10):4031-40. PubMed ID: 15899792
[TBL] [Abstract][Full Text] [Related]
5. [Treatment of cancer of unknown primary, today and future].
Shibata H
Gan To Kagaku Ryoho; 2009 Jun; 36(6):918-22. PubMed ID: 19542712
[TBL] [Abstract][Full Text] [Related]
6. Predicting the site of origin of tumors by a gene expression signature derived from normal tissues.
Staub E; Buhr HJ; Gröne J
Oncogene; 2010 Aug; 29(31):4485-92. PubMed ID: 20514016
[TBL] [Abstract][Full Text] [Related]
7. [An analysis of autopsy cases with cancer of unknown primary site].
Mandai K; Moriwaki S; Yamagami K; Saeki T; Yamauchi M
Rinsho Byori; 1994 Jan; 42(1):75-82. PubMed ID: 8107286
[TBL] [Abstract][Full Text] [Related]
8. A 30-year analysis of cardiac neoplasms at autopsy.
Butany J; Leong SW; Carmichael K; Komeda M
Can J Cardiol; 2005 Jun; 21(8):675-80. PubMed ID: 16003450
[TBL] [Abstract][Full Text] [Related]
9. Carcinoma of unknown primary (CUP).
Pavlidis N; Fizazi K
Crit Rev Oncol Hematol; 2009 Mar; 69(3):271-8. PubMed ID: 18977667
[TBL] [Abstract][Full Text] [Related]
10. [Cancer of unknown primary site origin--advances in diagnosis and therapy].
Plot L; Dovrish Z; Hadari R; Weisenberg N; Zehavi T; Nisenbaum B; Amital H
Harefuah; 2008 Apr; 147(4):294-8, 376, 375. PubMed ID: 18686808
[TBL] [Abstract][Full Text] [Related]
11. Markers of adenocarcinoma characteristic of the site of origin: development of a diagnostic algorithm.
Dennis JL; Hvidsten TR; Wit EC; Komorowski J; Bell AK; Downie I; Mooney J; Verbeke C; Bellamy C; Keith WN; Oien KA
Clin Cancer Res; 2005 May; 11(10):3766-72. PubMed ID: 15897574
[TBL] [Abstract][Full Text] [Related]
12. [CUP syndrome: are there advances?].
Moll R
Verh Dtsch Ges Pathol; 2005; 89():125-36. PubMed ID: 18035682
[TBL] [Abstract][Full Text] [Related]
13. Carcinoma of unknown primary (CUP); some considerations about pathogenesis and diagnostic strategy, particularly focusing on CUPS pertaining to the Urology.
Alberti C
G Chir; 2012; 33(1-2):41-6. PubMed ID: 22357439
[TBL] [Abstract][Full Text] [Related]
14. Cancer of unknown primary origin: a decade of experience in a community-based hospital.
Pimiento JM; Teso D; Malkan A; Dudrick SJ; Palesty JA
Am J Surg; 2007 Dec; 194(6):833-7; discussion 837-8. PubMed ID: 18005780
[TBL] [Abstract][Full Text] [Related]
15. Identification of tissue of origin in carcinoma of unknown primary with a microarray-based gene expression test.
Monzon FA; Medeiros F; Lyons-Weiler M; Henner WD
Diagn Pathol; 2010 Jan; 5():3. PubMed ID: 20205775
[TBL] [Abstract][Full Text] [Related]
16. Molecular assignment of tissue of origin in cancer of unknown primary may not predict response to therapy or outcome: a systematic literature review.
Pentheroudakis G; Greco FA; Pavlidis N
Cancer Treat Rev; 2009 May; 35(3):221-7. PubMed ID: 19046817
[TBL] [Abstract][Full Text] [Related]
17. The role of P501S and PSA in the diagnosis of metastatic adenocarcinoma of the prostate.
Sheridan T; Herawi M; Epstein JI; Illei PB
Am J Surg Pathol; 2007 Sep; 31(9):1351-5. PubMed ID: 17721190
[TBL] [Abstract][Full Text] [Related]
18. [The role of whole body 2-[fluorine-18]-fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography in the management of unknown primary tumors].
Wu ZJ; Zhang YX; Wei H; Jia Q
Zhonghua Yi Xue Za Zhi; 2007 Aug; 87(32):2253-6. PubMed ID: 18001544
[TBL] [Abstract][Full Text] [Related]
19. Diagnostic and therapeutic management of cancer of an unknown primary.
Pavlidis N; Briasoulis E; Hainsworth J; Greco FA
Eur J Cancer; 2003 Sep; 39(14):1990-2005. PubMed ID: 12957453
[TBL] [Abstract][Full Text] [Related]
20. Gene expression profiling to identify the histogenetic origin of metastatic adenocarcinomas of unknown primary.
Horlings HM; van Laar RK; Kerst JM; Helgason HH; Wesseling J; van der Hoeven JJ; Warmoes MO; Floore A; Witteveen A; Lahti-Domenici J; Glas AM; Van't Veer LJ; de Jong D
J Clin Oncol; 2008 Sep; 26(27):4435-41. PubMed ID: 18802156
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
